Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9)
Publication
, Journal Article
Ibarra-Drendall, C; Troch, MM; Barry, WT; Broadwater, G; Petricoin, EF; Wulfkuhle, J; Liotta, LA; Lem, S; Baker, JC; Ford, AC; Wilke, LG ...
Published in: Breast Cancer Research and Treatment
January 1, 2012
Duke Scholars
Published In
Breast Cancer Research and Treatment
DOI
EISSN
1573-7217
ISSN
0167-6806
Publication Date
January 1, 2012
Volume
135
Issue
3
Start / End Page
925
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ibarra-Drendall, C., Troch, M. M., Barry, W. T., Broadwater, G., Petricoin, E. F., Wulfkuhle, J., … Seewaldt, V. L. (2012). Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9). Breast Cancer Research and Treatment, 135(3), 925. https://doi.org/10.1007/s10549-012-2227-x
Ibarra-Drendall, C., M. M. Troch, W. T. Barry, G. Broadwater, E. F. Petricoin, J. Wulfkuhle, L. A. Liotta, et al. “Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9).” Breast Cancer Research and Treatment 135, no. 3 (January 1, 2012): 925. https://doi.org/10.1007/s10549-012-2227-x.
Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF, Wulfkuhle J, et al. Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9). Breast Cancer Research and Treatment. 2012 Jan 1;135(3):925.
Ibarra-Drendall, C., et al. “Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9).” Breast Cancer Research and Treatment, vol. 135, no. 3, Jan. 2012, p. 925. Scopus, doi:10.1007/s10549-012-2227-x.
Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF, Wulfkuhle J, Liotta LA, Lem S, Baker JC, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, Mehta P, Williams J, Tolbert N, Lee LW, Pilie PG, Yu D, Seewaldt VL. Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9). Breast Cancer Research and Treatment. 2012 Jan 1;135(3):925.
Published In
Breast Cancer Research and Treatment
DOI
EISSN
1573-7217
ISSN
0167-6806
Publication Date
January 1, 2012
Volume
135
Issue
3
Start / End Page
925
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences